-
Outlook Therapeutics Announces $11.2 Million Financings
Post on 6/23/20
-
INOVIO Receives $71 Million Contract From U.S. Department of Defense
Post on 6/23/20
-
Century Therapeutics Acquires Empirica Therapeutics
Post on 6/23/20
-
States that Have the Fewest Coronavirus Restrictions – Updated WalletHub Study
Post on 6/23/20
-
Better Buy: Verizon Communications vs. Johnson & Johnson
Post on 6/23/20
-
Novartis Shuts Down Hydroxychloroquine COVID-19 Clinical Trial
Post on 6/23/20
-
Provention Bio Closes Public Offering of Common Stock
Post on 6/22/20
-
Evergreen Theragnostics Completes $19 Million Series A
Post on 6/22/20
-
Better Buy: Novartis vs. Teva Pharmaceutical
Post on 6/22/20
-
Celldex Therapeutics Prices $130.4M Public Offering of Common Stock
Post on 6/21/20
-
Celldex Therapeutics Proposes Public Offering of Common Stock
Post on 6/21/20
-
Better Buy: Pfizer vs. Merck
Post on 6/19/20
-
Pfizer and Sangamo's Gene Therapy Continues to Help Patients with Hemophilia in Clinical Trial
Post on 6/19/20
-
Provention Bio Announces Pricing of $95.7 Million Public Offering of Common Stock
Post on 6/18/20
-
Provention Bio Announces Proposed Public Offering of Common Stock
Post on 6/17/20
-
Merck Prices $4.5 Billion Debt Offering
Post on 6/17/20
-
WellCare to Invest in Critical Mental Health Resources in New Jersey
Post on 6/17/20
-
KeyHIE Taps Longstanding Partnership with Orion Health
Post on 6/16/20
-
Bristol Myers Squibb Announces Commencement of Registered Exchange Offers
Post on 6/16/20
-
Fusion Pharmaceuticals IPO: Say No To One-Product Biotech IPOs
Post on 6/16/20
-
Health Partners Plans and Children's Hospital of Philadelphia Announce Agreement
Post on 6/15/20
-
Is Merck A Great Dividend Stock?
Post on 6/15/20
-
OraSure Technologies Receives BARDA Funding
Post on 6/14/20
-
Dr. Reddy's Laboratories Enters into a Licensing Agreement with Gilead Sciences for Remdesivir
Post on 6/14/20
-
Pharmaceutical Executive Reveals 20th Annual Pharma 50 for 2020
Post on 6/21/20
Philadelphia
